This inventor holds 1 USPTO granted patent. Top assignee: Yasutoshi Muto. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Hisataka Moriwaki: Innovator in Anticarcinogenic Drug Composition
Introduction
Hisataka Moriwaki is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of medicine, particularly in the development of anticarcinogenic drug compositions. His work aims to combat various forms of cancer, showcasing his dedication to improving health outcomes.
Latest Patents
Moriwaki holds a patent for an anticarcinogenic drug composition. This innovative composition effectively inhibits the recurrence of hepatocellular carcinoma and addresses the occurrence of other cancers, including cervical carcinoma intraepitheliale, lung adenocarcinoma, and mammary tumors. The drug composition is notable for its high safety profile and contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, Moriwaki has focused on research that targets critical health issues. His work has the potential to impact many lives by providing safer treatment options for cancer patients. His dedication to innovation in the pharmaceutical field is commendable.
Collaborations
Moriwaki has collaborated with notable colleagues, including Yasutoshi Muto and Mitsuo Ninomiya. These partnerships have likely contributed to the advancement of his research and the successful development of his patented drug composition.
Conclusion
Hisataka Moriwaki stands out as an influential inventor in the realm of anticarcinogenic drug development. His contributions are vital in the fight against cancer, and his innovative spirit continues to inspire advancements in medical research.